CDKN3 promotes tumor progression and confers cisplatin resistance via RAD51 in esophageal cancer

Purpose: Esophageal cancer (ESCA) progression and chemoresistance are critical factors that impact the survival of patients with esophageal cancer. Cyclin dependent kinase inhibitor 3 (CDKN3) is an important regulator of the cell cycle that has received little attention, therefore the purpose of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiansong, Che, Wencheng, Wang, Weimin, Su, Gongzhang, Zhen, Tianchang, Jiang, Zhongmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489875/
https://www.ncbi.nlm.nih.gov/pubmed/31114363
http://dx.doi.org/10.2147/CMAR.S193793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489875/
https://www.ncbi.nlm.nih.gov/pubmed/31114363
http://dx.doi.org/10.2147/CMAR.S193793

Ejemplares similares